American suppliers, now also on PeptideCompare

American suppliers on PeptideCompare

From now on, we're also including a number of carefully vetted American suppliers in the database, alongside our existing EU suppliers. Some of them have their own warehouse in the EU and simply ship locally; others ship directly from the US.

Either way, the same independent verification applies as for every other supplier on the site — where a supplier is based doesn't change how critically we look at them.

Does anything change about ordering?

For parcels from the US, a small amount of import duty is added. Since the customs rules changed in July 2026, a flat rate of €3 per parcel applies to shipments under €150. For most orders on this site, that's the only practical difference.

Beyond that, ordering from an American supplier works just like ordering from a European one: you order through their own site, and the supplier handles shipping and customs themselves.

How do we vet American suppliers?

The same standard as always, regardless of where a supplier is based:

• A valid COA per product, no older than 12 months.
• Clear labeling: for laboratory research only, not for human consumption.
• Careful packaging for the longer trip across the Atlantic, with a reshipment guarantee if something goes wrong along the way.
• Verification of the company itself, and — where possible — the same contact and trust-building we pursue with every supplier, not just paperwork.

What does this mean for you?

• More choice. Some compounds and formulations are available from American suppliers earlier, or exclusively, before they're widely available from EU suppliers.
• More competition, sharper prices. More suppliers side by side on one page means a fairer price comparison — exactly what this site exists for.
• Less dependence on one region. If an EU supplier is temporarily out of stock or stops trading, you now have alternatives on the other side of the ocean too.
• A different manufacturing origin. Some of these suppliers manufacture in the US themselves, rather than sourcing from the same manufacturers as many EU suppliers — more diversity in supply chains, and more basis for comparison.

What does “USA made” actually mean?

Some American suppliers market themselves as “USA made” — synthesized in their own lab, rather than sourced and repackaged from peptides already made elsewhere (often China). What they typically claim: production under cGMP-like guidelines, full documentation of every synthesis step, and shorter lead times because there's no international supply chain in between.

Worth noting: those are claims made by the suppliers themselves, not independently verified facts — just like any other claim on a supplier's website. So we don't simply take “USA made” as a quality mark; as always, we look at the COA, the contact, and the actual experience, not the label on the package. It is an interesting data point for researchers specifically looking for a different supply chain than the usual one.

Some context: how big is the peptide industry, actually?

Globally, the broader pharmaceutical peptide market was worth about $140.9 billion in 2025, with North America accounting for nearly 62% of that — the US is by far the largest player here. Europe is a solid second market, but the fastest growth right now is in Asia-Pacific.

Note: this is about the broader, approved pharmaceutical peptide market — think GLP-1 medication, insulin — not specifically the research-peptide market we operate in. No official market data exists for that, since it's an unregulated niche. These figures mainly show how large and mature the underlying American industry is.